You will be redirected to our submission process. Computational biology and systems bioinformatics are entering a transformative phase where the integration of multi-layered biological data has become ...

Revvity, Inc. (RVTY) is a life sciences and diagnostics company that develops technologies, software, and services supporting ...

Complete analysis pipeline for an integrated multi-omics study of dwarf tomato (Solanum lycopersicum cv. Red Robin) grown aboard the International Space Station (ISS) during the VEG-05 experiment. The ...

Plants face a wide range of environmental stresses — including drought, salinity, temperature extremes, and pathogen attack — that severely impact agricultural productivity and threaten global food ...

Bayesian multimodal modeling with explainable artificial intelligence to predict response to GBE1-targeted metabolic therapy in colorectal cancer. This is an ASCO Meeting Abstract from the 2026 ASCO ...

Interaction of DLL3-targeting CAR-T cells with the JAK1 inhibitor in treating small cell lung cancer. This is an ASCO Meeting Abstract from the 2026 ASCO Breakthrough. This abstract does not include a ...

scMOCHA is an end-to-end pipeline for calling mitochondrial mutations from single-cell RNA-seq data. The pipeline is designed to work with multi-version 10X Genomics data, and includes quality control ...

Patent-Pending Multi-Agent Architecture Targets Fragmented Biomedical Data and Expands Toward Imaging, Omics, and Broader ...

Revvity, Inc. (NYSE: RVTY) announced that its Revvity Signals Software business has joined Anthropic's directory for Model Context Protocol (MCP) connectors, enabling scientists to access Signals AI ...

As instruments grow faster, leaders say clinical impact will depend on trust, standards, data, and assays built for real ...

U.S. Spatial Genomics and Transcriptomics Market to Grow from USD 0.26 Billion to USD 0.71 Billion by 2035, While Europe ...